Europe — EMA
Pankaine Glucose (Bupivacaine Hydrochloride, Anhydrous)
GNH USA supplies Pankaine Glucose (Bupivacaine Hydrochloride), a local anesthetic for surgical anesthesia, pain management and intrathecal anesthesia.
Request sourcing
What is Bupivacaine Hydrochloride, Anhydrous?
Bupivacaine Hydrochloride, the active ingredient in Pankaine Glucose, is a local anesthetic presented as a sterile solution for intrathecal use. It provides profound sensory and motor block for surgical anesthesia and pain management in adult patients undergoing operative procedures.
GNH USA supplies Pankaine Glucose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide. The company ensures quality compliance with EU standards and offers reliable global distribution to healthcare institutions, including academic medical centers and surgical clinics, and adheres to stringent pharmacovigilance protocols.
What is Bupivacaine Hydrochloride, Anhydrous used for?
Bupivacaine Hydrochloride is employed as a local anesthetic for procedures requiring spinal or regional nerve block.
- Surgical anesthesia: provides dense sensory and motor block for operative procedures. - Pain management: enables regional analgesia for postoperative or chronic pain control. - Intrathecal anesthesia: facilitates spinal anesthesia for lower‑body surgeries and obstetric procedures.
What are the side effects of Bupivacaine Hydrochloride, Anhydrous?
Bupivacaine Hydrochloride may be associated with a range of adverse reactions, varying from mild to severe.
Common Side Effects: - Hypotension: transient drop in blood pressure following spinal block. - Bradycardia: slowed heart rate due to autonomic blockade. - Nausea: mild gastrointestinal upset after administration. - Pruritus: localized itching, often at the injection site.
Serious or Rare Side Effects: - Cardiac arrest: severe conduction disturbances leading to loss of cardiac output. - Seizures: central nervous system toxicity presenting as convulsions. - Respiratory depression: inadequate ventilation requiring support. - Allergic reactions: anaphylaxis or severe hypersensitivity.
What precautions apply to Bupivacaine Hydrochloride, Anhydrous?
When using Pankaine Glucose, clinicians should observe several safety measures.
- Patient assessment: evaluate cardiac, respiratory and CNS status before intrathecal administration. - Dose selection: use the lowest effective dose and adjust for patient weight and comorbidities. - Monitoring: maintain continuous cardiovascular and respiratory monitoring during and after injection. - Contraindications: avoid use in patients with known hypersensitivity to amide local anesthetics or severe spinal canal pathology. - Drug interactions: exercise caution when co‑administered with other CNS depressants or vasodilators. - Store at ambient temperature: keep in original container, protect from light and moisture.
What does Bupivacaine Hydrochloride, Anhydrous interact with?
Bupivacaine Hydrochloride can interact with several drug classes.
Major Interactions (Avoid): - Other local anesthetics: additive toxicity risk. - Potent CYP3A4 inhibitors (e.g., ketoconazole): increased plasma concentrations. - Systemic vasodilators (e.g., nitroglycerin): heightened hypotensive effect.
Moderate Interactions (Monitor Closely): - Sedatives or opioids: enhanced central nervous system depression. - Beta‑blockers: potential for profound bradycardia. - Diuretics: may alter plasma volume affecting drug distribution.



